Skip to content
PawLabel
active substance

Trilostane — veterinary medicines

Authorised animal medicines containing Trilostane across national registers. Regulatory residue limits (MRL) and antimicrobial-resistance surveillance are shown when on record. This is a neutral reference and does not provide dosing or veterinary advice.
Reference information only — not veterinary advice and not a dosing source. Always consult a licensed veterinarian before giving any medicine to an animal.

Target species

Dogs

Authorised products

65 authorised products across national registers.

United States — DailyMed (NLM)

United States — FDA Green Book

Residue limits (MRL)

No residue limits (MRL) are recorded for this substance.

Antimicrobial resistance surveillance

No antimicrobial-resistance surveillance is recorded for this substance.

Reported adverse events (openFDA)

Spontaneous adverse-event reports that name Trilostane, by species — reported counts, not proven reactions.

Dog

11,705 reported events

openFDA

Top reactions: Vomiting (1,992) · Lethargy (see also Central nervous system depression in 'Neurological') (1,973) · Hyperkalaemia (1,741) · Elevated serum alkaline phosphatase (SAP) (1,687) · Weight loss (1,478)

Source: openFDA Animal & Veterinary adverse-event reports.

Surveillance reference only — these are spontaneous adverse-event report counts, not proven adverse reactions, not causation and not a measure of any product's risk or safety. Always consult a licensed veterinarian.

Get free recall alerts

Reading about Trilostane? Pet products get recalled all the time — get a free email when a new pet-relevant recall is published. Unsubscribe any time.

Opt-in only: we store your email, language, optional species filter and the page you signed up on, and send a welcome email with a one-click unsubscribe link. We never share your address.

Explore